Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (1158)	4/15/1998 10:40:00 AM
From: Early Out	Read Replies (1) \| Respond to of 9523

One point that I have expressed before is that these mild and psychologically based ED patients are going to be "cured" by a short time on Viagra and they will NOT represent a source of recurring revenue for this drug. But the point is there will always be a base of people with a temporary need for the drug. Sure, the base won't be the same as last month, but it will continually churn. I still haven't seen much reference to medically induced ED, but my pharmacist wife tells me there are a lot of prescription drugs that do this, and that represents a market that will continue to exist, despite perhaps not getting reoccuring business quite like the razor business. Has there ever been a better business model than "give away the razor and sell the blades"? I can't think of one... -jsc